According to Straits Research , the global candidiasis therapeutics market size was valued at USD 2.90 billion in 2025 and is projected to grow from USD 3.01 billion in 2026 to USD 4.07 billion by 2034, recording a CAGR of 3.83% during the forecast period (2026–2034). North America held the largest market share of 32.86% in 2025, while Asia Pacific is set to record the fastest growth at a...
Precision Business Insights has published a report on the global invasive fungal infection market, estimating its value at USD 24.3 billion in 2024 and is expected to expand at a compound annual growth rate (CAGR) of 9.1% over the forecast period 2025-2031. The report explores the market growth and potential opportunities in the market industry. Additionally, it offers a detailed analysis of...